ArticleBMC cardiovascular disorders2026
Time for contrast to pass through the myocardium and its association with angina severity in patients with non-obstructive coronary artery disease.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA substantial number of patients with angina and non-obstructive coronary disease (ANOCA) remain symptomatic despite the absence of flow-limiting lesions, and accumulating evidence suggests an increased risk of adverse outcomes and healthcare utilization. This study aimed to evaluate a simple angiographic index that may reflect myocardial perfusion and correlate with symptom burden in patients with ANOCA.
methodsIn this cross-sectional study, we enrolled 102 patients with angina and angiographically confirmed non-obstructive coronary artery disease. All patients underwent coronary angiography using a standardized, automated contrast injection protocol. The time for contrast to pass from the left coronary ostium to the coronary sinus (TCPM) was measured fluoroscopically and indexed to myocardial mass, heart rate, and mean arterial pressure, resulting in the indexed Time for Contrast to Pass through the Myocardium (iTCPM). Symptom severity was assessed using the Canadian Cardiovascular Society (CCS) classification and the Seattle Angina Questionnaire (SAQ). Correlations and between-group analyses were performed.
resultsThe mean iTCPM was 4.97 ± 1.02 s. iTCPM showed a positive correlation with CCS class (Spearman’s ρ = 0.443, p < 0.00001). iTCPM was inversely correlated with key SAQ scale results including angina frequency (ρ = − 0.460), physical limitation (ρ = − 0.317), and disease perception (ρ = − 0.206). Patients with slower iTCPM demonstrated significantly higher symptom burden.
conclusionThe iTCPM offers a simple, quantitative angiographic index that is associated with symptom burden in patients with ANOCA and may reflect altered myocardial contrast transit. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.